SKIN HEALTH: WHAT ACTUALLY MATTERS

ACNE

Evidence-Ranked Treatment Ladder

1. Mild: Adapalene 0.1% (OTC) + BPO 2.5% — $15–25/month C1
2. Moderate: Add oral doxycycline short-term, or spironolactone for women ($17/month) C1
3. Moderate-severe: "Acne trio" — retinoid + BPO + topical antibiotic (MD = 38.15) C1
4. Severe/resistant: Isotretinoin (MD = 48.41, ranked #1 across 221 RCTs) — ~73% durable clearance at ≥220 mg/kg cumulative dose C1
5. Hormonal (women): Spironolactone (OR 6.59, beats doxycycline 62% vs 32%) or COCs (55% reduction at 6 months) C1

Key Stats

• BPO 2.5% = 10% for efficacy (72.7% inflammatory lesion reduction) with far fewer side effects — use the lower concentration
• Isotretinoin MD = 48.41 — far ahead of all other treatments in the largest acne meta-analysis ever (65,601 patients)
• Spironolactone OR 6.59 — arguably the best value in acne treatment at $17/month
• No oral antibiotic is superior to another — choose by side-effect profile, not efficacy

Don't Overlook

• Diet: Low-GI diet reduced lesions by 23.5 vs 12.0 (control) C2
• Zinc: 30–58% inflammatory papule reduction C2
• Fungal acne: Monomorphic itchy bumps on trunk that worsen on antibiotics. Treat with oral itraconazole (~80% recovery). Often misdiagnosed as acne vulgaris C2

SCARRING

Scar Type Identification — This Matters Enormously

• Ice pick (60–70% of atrophic scars): narrow, deep, V-shaped
• Boxcar (20–30%): broad, flat-bottomed depressions
• Rolling (15–25%): undulating, tethered from below
• Hypertrophic: raised, stays within wound borders, may regress
• Keloid: raised, extends beyond wound borders, does NOT regress. 15–20× more common in African descent

Best Treatment by Type

• Ice pick → TCA CROSS (65–100% TCA) — the only treatment that excels here C1
• Rolling → Subcision + filler (must release fibrous tethering first) C1
• Boxcar → Fractional CO₂ laser (26–50% improvement per session) C1
• Hypertrophic/Keloid → 5-FU + TAC injection (77% efficacy, 17.5% recurrence — superior to TAC alone) C2

Realistic Expectations

50–80% improvement is an excellent outcome. Complete resolution is rare. Combination approaches consistently outperform monotherapy (20–50% for single treatments). Most patients have mixed scar types requiring a multi-step protocol.

Cost: Budget pathway $1,500–5,000 · Comprehensive $12,000–25,000+

Prevention Is Everything

• Silicone sheets/gel: first-line prevention for surgical/injury scars (subgroup RR 0.46 in high-risk patients) C2
• Moist wound healing: 2× faster re-epithelialization C1
• Vitamin E on scars: 90% showed no effect or worsened; 33% got contact dermatitis. Don't use it C2
• Mederma: No better than petrolatum ($3) in gold-standard RCTs C1
• Stretch marks: No topical prevents them (Cochrane). Striae rubrae respond to laser; striae alba are very resistant.

HYPERPIGMENTATION

Melasma — The Hardest to Treat

A chronic disease with 41–60% recurrence. Requires lifelong management.

1. Tinted SPF with iron oxide — blocks visible light, which standard sunscreens don't. A 2025 RCT showed tinted SPF (VPFF 66) was significantly better than untinted SPF 50 C1
2. Oral tranexamic acid 250mg BID — ~59% MASI reduction at 12 weeks, safe up to 28 months. DVT risk extremely low at melasma dose C1
3. Hydroquinone 4% cyclically — ~40% clearance monotherapy (blinded), ~80% in combination regimens. Cycle 3–6 months on/off to avoid ochronosis C1
4. Tretinoin + azelaic acid for maintenance — azelaic acid 20% is comparable to HQ 4% with no cycling needed C1
5. Lasers: LAST resort — 64–81% recurrence at 3 months, up to 31% risk of worsening C2

Post-Inflammatory Hyperpigmentation (PIH)

Sunscreen alone improved 81% of dark-skinned patients within 8 weeks C2. PIH is reactive and tends to self-resolve (epidermal: 6–12 months). Add azelaic acid 15% for faster clearing. Treat the underlying inflammation aggressively.

Sun Spots (Solar Lentigines)

The best laser indication: Q-switched or picosecond laser, 1–3 sessions, $300–1,500 total, durable results. Low recurrence. Far more responsive than melasma C2.

The Visible Light Problem

Visible light makes up 50% of solar radiation (UV is only 5%). Standard sunscreens don't block it. In darker skin, visible light causes darker and more sustained pigmentation than UV. Tinted sunscreens with iron oxide are standard of care for any pigmentation concern.

ROSACEA

Evidence-Ranked Treatment Ladder

1. First-line (papulopustular): Ivermectin 1% cream (Soolantra) — 83% inflammatory lesion reduction; beat metronidazole head-to-head (84.9% vs 75.4% clear/almost clear, n=962) C1
2. First-line (alternative): Azelaic acid 15% — FDA-approved for rosacea, 70% comedone reduction, also treats co-existing PIH C1
3. Classic first-line: Metronidazole 0.75% — 65% inflammatory lesion reduction (meta-analysis, 5 RCTs), well-tolerated but inferior to ivermectin C1
4. Anti-inflammatory oral: Low-dose doxycycline 40mg MR — sub-antimicrobial dose, does NOT affect bacterial flora, FDA-approved for rosacea C1
5. Persistent redness/vessels: IPL — 77.8% achieve >75% clearance for erythematotelangiectatic rosacea (meta-analysis) C2

Key Stats

• Ivermectin > metronidazole — the ATTRACT study (n=962) settled this. Ivermectin is the new standard of care for papulopustular rosacea
• Low-dose doxy (40mg) is NOT an antibiotic at this dose — it works via MMP inhibition. No resistance concerns, no gut microbiome disruption
• Demodex mites are found at 5-10x higher density on rosacea skin. Ivermectin's dual anti-parasitic + anti-inflammatory action addresses this directly
• Tinted SPF with iron oxide is critical — visible light triggers flushing. Standard sunscreen is not enough

What Doesn't Work / Common Mistakes

• Retinoids (initially): Tretinoin causes barrier disruption that worsens rosacea flushing. If needed, start extremely low and slow after rosacea is controlled
• AHA/BHA exfoliants: Active rosacea is a contraindication. Wait until calmed, then PHAs only, max 1x/week
• Topical steroids: Provide short-term relief but cause steroid rosacea with chronic use — a common trap
• Gut connection: SIBO is more common in rosacea patients, but treating SIBO does NOT reliably resolve rosacea. Probiotics remain C3-C4 evidence

DRYNESS / ECZEMA

The Barrier Science That Actually Matters

Dry skin is a barrier dysfunction problem, not a "hydration" problem. The stratum corneum is a "bricks and mortar" structure: corneocytes (bricks) held together by ceramides, cholesterol, and fatty acids (mortar) in a precise 1:1:1 molar ratio. When this lipid matrix breaks down, transepidermal water loss (TEWL) skyrockets and skin becomes dry, tight, and reactive.

Evidence-Ranked Treatment Ladder

1. Ceramide moisturizers — restore the actual lipid barrier. Significant SCORAD improvement (meta-analysis, p=0.003). CeraVe at $4-8/month performs comparably to luxury brands C2
2. Petrolatum — at just 5% concentration, reduces TEWL by >98%. Has 170x greater vapor resistance than olive oil. Apply to damp skin C1
3. Niacinamide 2-5% — stimulates endogenous ceramide biosynthesis (4.1-5.5 fold increase in vitro). 34-67% ceramide synthesis boost at 2-5% in vivo C1
4. Hyaluronic acid — humectant holding 1,000x its weight in water. Standard HMW: surface hydration only. LMW: 14-19% skin penetration, wrinkle reduction C2
5. For eczema/AD: Tacrolimus/pimecrolimus (calcineurin inhibitors) — steroid-sparing, safe for face and long-term use C1

Key Stats

• SLS exposure increases TEWL 8-fold (5.1 to 42.6 g/m2/h) — ditch harsh cleansers. This one change matters more than any serum
• Barrier repair timeline: mild damage 3-5 days, moderate 2-4 weeks, severe up to 6 weeks. The SC turns over every 2-4 weeks
• Cholesterol-dominant 3:1:1:1 ratio repairs barrier fastest in aged skin — this is why multi-lipid moisturizers beat single-ingredient ones
• Filaggrin mutations (~10% of Europeans) cause lifelong dry/eczema-prone skin — these people especially need ceramide-based care
• Women lose ~40% of sebum production by the 6th decade; men remain stable until the 8th. Post-menopausal dryness is hormonal, not cosmetic

What Doesn't Work / Common Mistakes

• Alkaline soap (pH >7): Increases protease activity, impairs ceramide processing, shifts microbiome toward pathogens. Use pH 4.5-5.5 cleansers
• Over-exfoliation: AHAs/BHAs on already-compromised skin make everything worse. Stop all actives until barrier recovers
• "8 glasses of water": Systematic review shows minimal effect on skin hydration unless you are actually dehydrated C3-C4
• Hyaluronic acid in dry climates: Without adequate humidity, HA can pull water FROM your skin. Always seal with an occlusive on top

HAIR LOSS

Evidence-Ranked Treatment Ladder (Androgenetic Alopecia)

~95% of hair loss in men is androgenetic alopecia (AGA). Treatment works best when started early. Nothing regrows a fully bald scalp.

1. Minoxidil 5% topical (OTC) — 18.6 hairs/cm2 increase at 48 weeks. ~60% show moderate-dense regrowth. Must use indefinitely C1
2. Finasteride 1mg oral — blocks DHT conversion. 90% maintained or improved hair count at 5 years (vs 25% placebo). The gold standard C1
3. Combination minoxidil + finasteride — significantly better than either alone. This is the standard regimen dermatologists recommend C1
4. Oral minoxidil (low-dose, 0.25-5mg) — 60-90% report improvement. Increasingly prescribed off-label. Requires cardiac monitoring C2
5. Hair transplant (FUE/FUT) — 85-95% graft survival (systematic review), 87-97% satisfaction. The only permanent solution. $4,000-15,000 C1

Key Stats

• Finasteride side effects: sexual dysfunction in 1-2% of users (meta-analyses). Clears on discontinuation in the vast majority. Post-finasteride syndrome is controversial (no controlled evidence for persistent effects beyond nocebo)
• Topical finasteride is non-inferior to oral for hair count (+12.2 vs +11.7 hairs/cm2, n=458) with ~50% less serum DHT suppression — a real option if systemic side effects are a concern
• Women: use minoxidil 2% (5% increases facial hypertrichosis). Finasteride is contraindicated in pregnancy (teratogenic). Spironolactone is the main oral option
• Ketoconazole 2% shampoo showed hair density comparable to minoxidil 2% in one small RCT — useful adjunct at minimal cost

What Doesn't Work / Common Mistakes

• Biotin supplements (non-deficient): No benefit for hair loss. Causes lab test interference (FDA warning). The most overhyped supplement in dermatology C1 (negative)
• Waiting too long: AGA is progressive. Miniaturized follicles can be rescued; dead follicles cannot. Starting treatment at first signs of thinning yields dramatically better results
• "Hair growth" supplements: Viviscal, Nutrafol — mostly biotin + saw palmetto + marketing. No independent evidence rivaling minoxidil or finasteride
• PRP for hair: Comparable to minoxidil in some studies (~25 hairs/cm2 increase), but $500-1,500/session every 3-6 months. Poor cost-effectiveness vs $8-20/month for topical minoxidil C2

PORES / TEXTURE

The Reality About Pore Size

You cannot permanently shrink pores. Pore size is primarily determined by genetics and sebum production (which is highly heritable). What you CAN do: reduce the appearance of enlarged pores by clearing the debris inside them, normalizing oil production, and improving surrounding skin texture. Products claiming to "close" pores are lying.

Evidence-Ranked Treatment Ladder

1. Retinoids (tretinoin 0.025-0.05%) — normalize cell turnover, prevent pore-clogging, increase collagen around pores to tighten appearance. The single best long-term treatment C1
2. Salicylic acid 0.5-2% — oil-soluble BHA that penetrates INTO pores and dissolves sebum/debris. First-line for blackheads and congestion C1
3. Niacinamide 4-5% — regulates sebum production, improves pore appearance. 21% fine line improvement at 4-8 weeks C1
4. Glycolic acid 4-8% — surface exfoliation smooths skin texture. 76% achieved 1+ grade photodamage improvement. Complements BHA C1
5. Fractional CO2 laser — most dramatic pore refinement via collagen remodeling around follicles. Professional treatment, significant downtime C1

Key Stats

• Sebum production varies 3-4x between dry and oily skin types. Oily skin = larger pores, full stop. Sebum is driven by DHT
• Retinoids are the long game: pore appearance improves over months, not days. The collagen remodeling that makes the biggest difference takes 3-6 months
• AHA + BHA together work from different angles — AHA exfoliates the surface (water-soluble), BHA cleans inside the pore (oil-soluble). Alternate days to avoid over-exfoliation
• Isotretinoin dramatically reduces pore size by shrinking sebaceous glands up to 90%, but effects partially reverse after the course ends

What Doesn't Work / Common Mistakes

• Pore strips: Remove surface blackheads temporarily but do nothing for pore size. Pores refill within 24-48 hours
• "Pore-minimizing" primers: Cosmetic blur effect only. Silicone-based primers fill pores visually but don't treat them
• Over-cleansing: Stripping oil causes rebound sebum production. Gentle cleanser, not "deep pore cleansing"
• Ice/cold water: Temporarily constricts blood vessels creating the appearance of smaller pores. Effect lasts minutes. Not a treatment

CELLULITE

What It Actually Is

Cellulite is structural, not a fat problem. Vertically-oriented fibrous septae pull down on female skin, creating dimples. Fat herniates between them secondarily. This is why thin women get cellulite. It affects 80–90% of postpubertal women — it's essentially normal female anatomy C1.

What Works

• Cellfina subcision: 93% improved, 5-year durability (FDA-cleared), $2,500–6,500 one-time C1
• Cellulaze laser: 90% site improvement, 1–3 year durability, $3,000–6,000 C2
• Resonic acoustic subcision: 34% CSS improvement, 1+ year data, ~$3,000–5,000 C2
• Exercise: modest benefit (less fat + more muscle = less visible), not a cure C2

What Doesn't Work

Dry brushing, cupping, compression garments, cryolipolysis, most topical creams, mesotherapy — all C4–C5 evidence. The cellulite industry is rife with claims that exceed the science.

QWO — What Happened

Collagenase injection that met FDA trial endpoints but was withdrawn December 2022 due to 84% bruising rate and prolonged skin discoloration. The science was sound; the side effects were commercially unviable.

LAXITY

The Uncomfortable Truth

Non-surgical treatments achieve roughly 20–30% of a facelift's lifting effect (clinical consensus estimate). For moderate-to-severe laxity, surgery is the only evidence-based answer. Marketing the term "non-surgical facelift" is misleading.

What Works, Honestly

• Mild laxity: Tretinoin + vitamin C + sunscreen (prevention/slowing)
• Best non-surgical tightening: Fractional CO₂ laser — significant downtime but strongest collagen contraction C1
• Deep plane facelift: 94.4% satisfaction (n=2,896 meta-analysis), lasts 10–15+ years, $17,000–46,000 C1

Avoid: Thread Lifts

In a 160-patient study, all initial lifting was absent at 1 year with dissolvable threads. Complication rate: 35% swelling, 10% dimpling, 6% paresthesia. Scar tissue from threads can make future facelift surgery harder C3–C4.

The 10-Year Math

• Non-surgical maintenance (annual Ultherapy + biannual Morpheus8): ~$55,000 over 10 years with inferior results
• Deep plane facelift: $17,000–46,000 one-time with superior, lasting results
• Prevention (SPF + tretinoin + vitamin C): $5,300–16,400 over 10 years — by far the most cost-effective approach